Annual Drug Patent Expiration for ELCYS
Elcys is a drug marketed by Exela Pharma and included in one NDA. It is available from a single supplier. There are ten patents protecting this drug.
Drug patent litigation for ELCYS.
The generic ingredient in ELCYS is cysteine hydrochloride. One registered supplier for this compound. Additional details are available on the cysteine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug Exela Pharma ELCYS